Discovery Pharmacokinetics Brochure

Our preclinical services facilities provide rapid non-GLP pharmacokinetic (PK) screening studies to assist our sponsors in lead candidate selection from libraries of compounds. Our high-throughput bioavailability screening includes formulation, in vivo, bioanalytical and PK reporting services.

Highlights

• Ability to meet aggressive timelines for outsourced PK programs
• Short lead time for study initiation
  • Study starts within five-seven days of inquiry
• Rapid turnaround times on in-life and bioanalytical studies 
  • Four-seven business days from receipt of test articles to submission of report, including PK calculations on bioanalytical data 
• Flexible scheduling to allow last-minute changes to study protocol
• Standardized, abbreviated protocols and reporting methods